AdaptHealth Sees Unusually High Options Volume (NASDAQ:AHCO)

AdaptHealth Corp. (NASDAQ:AHCO - Get Free Report) was the target of unusually large options trading activity on Tuesday. Investors bought 4,503 put options on the stock. This represents an increase of approximately 53% compared to the typical daily volume of 2,939 put options.

Hedge Funds Weigh In On AdaptHealth

A number of large investors have recently made changes to their positions in AHCO. Intech Investment Management LLC raised its position in AdaptHealth by 223.2% in the 3rd quarter. Intech Investment Management LLC now owns 59,650 shares of the company's stock worth $670,000 after purchasing an additional 41,196 shares during the period. Victory Capital Management Inc. raised its holdings in shares of AdaptHealth by 727.4% in the third quarter. Victory Capital Management Inc. now owns 141,507 shares of the company's stock worth $1,589,000 after buying an additional 124,404 shares during the period. Royce & Associates LP raised its holdings in shares of AdaptHealth by 13.5% in the third quarter. Royce & Associates LP now owns 777,405 shares of the company's stock worth $8,730,000 after buying an additional 92,740 shares during the period. Barclays PLC lifted its stake in shares of AdaptHealth by 361.3% during the 3rd quarter. Barclays PLC now owns 181,240 shares of the company's stock worth $2,034,000 after acquiring an additional 141,949 shares during the last quarter. Finally, Principal Financial Group Inc. boosted its holdings in AdaptHealth by 39.7% during the 3rd quarter. Principal Financial Group Inc. now owns 543,744 shares of the company's stock valued at $6,106,000 after acquiring an additional 154,434 shares during the period. 82.67% of the stock is owned by hedge funds and other institutional investors.

AdaptHealth Trading Up 2.6 %

NASDAQ AHCO traded up $0.29 on Friday, hitting $11.38. 1,758,793 shares of the stock were exchanged, compared to its average volume of 1,099,112. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24. AdaptHealth has a 52-week low of $8.35 and a 52-week high of $11.90. The firm has a market capitalization of $1.53 billion, a P/E ratio of -6.90, a P/E/G ratio of 1.08 and a beta of 1.12. The stock has a fifty day moving average price of $9.92 and a two-hundred day moving average price of $10.23.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on the company. Robert W. Baird lifted their target price on AdaptHealth from $14.00 to $16.00 and gave the stock an "outperform" rating in a report on Thursday. UBS Group cut their target price on shares of AdaptHealth from $12.00 to $11.00 and set a "buy" rating for the company in a report on Thursday, February 13th. Canaccord Genuity Group upped their price target on shares of AdaptHealth from $13.00 to $14.00 and gave the company a "buy" rating in a research note on Wednesday. Truist Financial lifted their price objective on shares of AdaptHealth from $12.00 to $14.00 and gave the stock a "buy" rating in a research note on Wednesday. Finally, Royal Bank of Canada upped their target price on shares of AdaptHealth from $11.00 to $14.00 and gave the company an "outperform" rating in a research report on Wednesday. Five equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, AdaptHealth has an average rating of "Buy" and a consensus price target of $13.80.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.